FDA Investigator Jennifer A Longie Vollom

Jennifer A Longie Vollom has conducted inspections on 225 sites in 2 countries as of 18 Jan 2024. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
225
Last Inspection Date:
18 Jan 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America, Canada
FDA Investigators that have inspected at least one site in common with Jennifer A Longie Vollom:
Aaron L Dunbar, Aimee J Edwin, Alan R Albrecht, Aldo J Milone, Alfred P Pistorio, Alicia M Mozzachio, Alison A Nicoli, Allen F Hall, Amy L Mcintyre, Ana M Placencia, Anderson, Andrea B Slavin, Anthony J Ladner, Anthony L Nicoli, Antoinette L Chancey, April L Brown, April L Young, Barbara M Frazier, Billi Jom Johnson, Boun M Xiong, Bradley A Servais, Brian D Garthwaite, Brian E Thompson, Brian L Szcyubialka, Brunilda Torres, Carl J Montgomery, Carol Rivera Lopez, PhD, Carolyn A Warren, Catherine M Vanderhoef, Charles R Cote, RIC, Cheryl A Kmiec, Christina A Castineyra, Christine M Erickson, Christine M Whitby, CSO, Clotia Cabbey Mensah, Courtney R Ingalsbe, Courtney R Tiegs, Craig R Berger, Dacia E Quick, Danielle Dborchert Fs, Darlene L Krieger, Darren D Holaday, David B Wieneke, Demetria L Lueneburg, Denise L Burosh, Diane M Fresch, Diane T Reindl, Dianna C Sonnenburg, Douglas J Snyder, Dr. Sriram Subramaniam, PhD, Duc Minh H Nguyen, Edward A Fabiano, Edward M James, Elizabeth E Hart (ASCP), MT, Elizabeth P Mayer, Ellen C Weisensel, Emily E Harlow, Emily E Markgraf, Eric T Huebler, Erin Norling, Fannie M Harrell, Frank S Sedzielarz, Frederick J Tillman, Gina M Scholze, Grant M Ruis, Greg A Abel, Gregory A Berg, Gregory S Larson, Gregory W Smith, Heather Akleimola Hulbert, Howard A Burmester, Ivan E Reyes, J Benedict, Jaclyn N Munsch, Jacob W Reynolds, Jacqueline A O'shaughnessy, PhD, James A Beaulieu, James K Ireland, James R Evans, James R Fleckenstein, James W Plucinski, Jan L Hewett, Jane E Nelson, Janis R Armedoriz, Jean M Bosenbecker, Jean M Trimbo, Jeanne M Morris, Jeffery A Hangartner, Jennifer Al Vollon, Jennifer J Edmiston, Jennifer R Mathern, Jeremy L Tri, Jeremy R Read, Jessica L Barr, Jessica L Diliberti, Jessica L Johnson, Jessica M Novak, Jocelyn C Turner, Jocelyn M Muggli, Joel D Hustedt, John A Kadavil, PhD, John E Verbeten, John M Seale, Jon C Polzine, Jonathan L Blonk, Joseph M Edwin, Judy Ellen Ciaraldi, Julie Woodberry, Justin A Boyd, Justin J Jafferis, Karen M Kondas, Karen M Labounty, Karla J Youngberg, Kathryn M Mogen, Kellie L Thommes, RN, Kellie L Westerbuhr, Kenneth A Libertoski, Kevin A Swiss, PhD, Kevin P Regan, Kibily D Dembele, Kimberly W Destromp, Kristy E Zuroski, Kyle J Mccracken, Larae M Koopman, Larry K Austin, Lauren E Sanger, Leonardm, Lesley A Swanson, Linda V Weyer, Lisa M Lopez, Mada A Tautges, Margaret L Bolte, Margaret M Annes, Margaret M Lubbers Solberg, Maria E Treadwell, Marie A Fadden, Marion Hinnenkamp, Mark I Kaspar, Martin K Yau, PhD, Mary M Finn, Melanie C Voges, Melissa D Kalik, Melissa I Michurski, Michael Smith, Michelle J Glembin, Mohammed H Adam, Nicole C Victoria, PhD, Nicole J Clausen, Nilufer M Tampal, PhD, Norman L Brown, Paola E Lathrop, Peter T Erlandson, Rebecca L Caulfield, Rebecca L Keller, Richard Jay Tucker, RS, Robert C Steyert, Robert F Leuer, MDA, Robert H Claflin, Robert J Waldorf, Robert M Tillman, Rosemary Wood Sexton, Ross J Grigsby, Rostislav Servetnyk, Sana A Elassar, Sandra Sejdinovic, Scott A Golladay, Scott B Laufenberg, Scott L Schenian, Shannon A Dinardo, Sharon K Thoma, PharmD, Sharon L Matson, Sharon M Harold, Shaun M Olson, Sripal R Mada, PhD, Stacie Schanus, Steven J Crowston, Sullan, Susan M Miller, Tara C Singh, Tara M Carolfi, Theresa C Klaman, Thomas S Donaldson, Timothy R Marrs, Traci C Kelm, Troy A Brenny, Victoria L Palmer, Wayne W Grundstrom, Wendy L Trefethren Grang, William E Keer, William G Craig, William P Fournier, William R Weissinger, Xikui Chen (nmi), PhD, Yehualashet A Gessesse, Yiyue Zhang (nmi), PhD, Yuriy Solovyov, Yvette E Guillermo, Zachary P Wachlarowicz

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more